Stay updated on Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Sign up to get notified when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A site-wide update to revision v3.4.2 was applied and a government funding notice was removed; there are no changes to the study details, eligibility criteria, or results on this page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:34:54.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about government funding status was added, and the page version was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:23:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', while removing the previous lowercase variants. The page revision header now shows Revision: v3.4.0 instead of v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T00:22:47.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 in place of the previous v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:46:32.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A consolidated Locations section has been added listing study sites across multiple states (Arkansas, California, Florida, Georgia, Maryland, Mississippi, New Jersey, Texas). The previous per-state location subsections have been removed.
    Difference
    1.0%
    Check dated 2025-12-23T17:13:03.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:15:37.000Z thumbnail image

Stay in the know with updates to Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.